Malignant Neoplasm of Unknown Primary — Trials

Malignant Neoplasm of Unknown Primary — Trials · CancerIndex

Clinical trials

Registered studies

14,247 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 4,158
Recruiting: 2,257
Ph III recruiting: 267
Growth YoY: +13.5%
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,894)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02081755	Safety and Efficacy of Everolimus Treatment in Liver Transplantation for Liver Cancer	enrolling by invitation	Phase 4	336	Baylor Research InstituteOTHER	1	Jan 27, 2026	clinicaltrials
NCT07034859	Cabergoline in the Management of Nonfunctioning Pituitary Adenoma	enrolling by invitation	Phase 4	30	National Taiwan University HospitalOTHER	1	Jun 24, 2025	clinicaltrials